Bambusa Therapeutics Inc.
Status: Publicly traded
Last reviewed: November 2026
Direct answer
Bambusa Therapeutics Inc. is publicly traded on NASDAQ under the ticker BBTX.
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
Can you invest in Bambusa Therapeutics Inc.?
Yes. Bambusa Therapeutics Inc. trades publicly on NASDAQ as BBTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Bambusa Therapeutics Inc.
Detailed equity research is provided by MarketSnap.